Ā | Twins (baseline) | Twins (post-intervention) | Twins (follow-up) | Singletons (baseline) | Singletons (post-intervention) | Singletons |
---|---|---|---|---|---|---|
Lost-to-follow-up/withdrew (%, n) | 0.00% (0) | 18.75% (6) | 28.13% (9) | 0.00% (0) | 21.21% (14) | 21.21% (14) |
PSEQ (%) | 0.00% | 9.38% | 15,63% | 0.00% | 16.67% | 18.18% |
PSFS | 0.00% | 9.38% | 15,63% | 0.00% | 16.67% | 18.18% |
NRS | 0.00% | 9.38% | 15,63% | 0.00% | 27.27% | 18.18% |
RMPQ | 0.00% | 18.75% | 28.13% | 0.00% | 21.21% | 21.21% |
IPAQ-SF | 0.00% | 12.50% | 18.75% | 15.15% | 18.18% | 22.73% |
DASS | 0.00% | 12.50% | 28.13% | 0.00% | 16.67% | 21.21% |
ISI | 0.00% | 12.50% | 15.63% | 0.00% | 16.67% | 19.70% |
SCI | 0.00% | 12.50% | 75.00%a | 0.00% | 16.67% | 21.21% |
PSQI | 0.31% | 18.75% | 18.75% | 1.59% | 21.21% | 21.21% |
Total average | 0.03% | 12.85% | 25.69% | 0.35% | 19.02% | 20.20% |
Ā | Twins | Singletons | ||||
Overall average | 12.86% | 13.19% |